| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PSA | Common Stock | Options Exercise | $458,350 | +1,666 | +30% | $275.12 | 7,208 | 26 Apr 2022 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PSA | Stock Option (Right to Buy) | Options Exercise | $0 | -1,666 | -33% | $0.000000 | 3,334 | 26 Apr 2022 | Common stock | 1,666 | $275.12 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | Includes 542 deferred stock units. |
| F2 | Stock Option granted pursuant to the 2016 Equity and Performance-Based Incentive Compensation Plan. Option vests in three (3) equal annual installments beginning one (1) year from the grant date. |
| F3 | This option to purchase 5,000 shares of common stock became exercisable as to one-third on April 26, 2022 and becomes exercisable as to one-third on each of April 26, 2023 and 2024. |